selgus, et patsiendil on kõrgenenud kolesterooli tase (8,9 mmol/l) ning vererõhku kontrollides selgus, et see on normist kõrgem (154/95mmHg). Seejärel tehti 24 h monitooruuring, mille tulemusena sai patsient diagnoosiks hüpertooniatõbi. Teadaolevalt pole perekonnas hüpertooniatõve esinenud. Patsient suitsetab 15-20 sigaretti päevas ja on seda teinud 30 aastat. Suitsetamisest loobumine on raske, sest naine armastab samuti suitsetada. Kodus tarvitatavad ravimid: vererõhuravim Noliprel Arginine, 2,5 mg/0,625 mg (1 tbl. 1 kord päevas), kolesterooli alandav ravim Atoris, 30 mg (1 tbl. päevas), D-vitamiini toidulisand. Patsient võtab ravimeid väga ebaregulaarselt. Analüüsid/uuringud: vere analüüs-kolesterool, 24 h monitooruuring. EKG, uriinianalüüs. Patsient on 175 cm/86kg (KMI 28.08). Patsiendile kehakaal muret ei tee, kuigi aasta jooksul on lisandunud 10 lisakilo (enamasti vöökohale, ümbermõõt 105cm). Toitumine: Enamasti sööb 2 korda päevas, lõunal ja õhtul
against the fluorescent peptide Suc-Leu- however, the neural form, nNOS, is thought Leu-Val-Tyr-AMC, regardless of the pH or to be the predominant isoform (Kaminski and ionic strength. Similar results were seen Andrade 2001). These enzymes utilize argi- when using purified myofibrils as the sub- nine as a substrate and catalyze the following strate. This inhibition was reversible, as reaction: L-arginine+NADPH+O2 forming addition of reducing agent (DTT) to the oxi- L-citrulline+•NO+NADPH+. NO is important dized samples restored activity. Oxidation in biological systems, particularly because of also has been shown to slow the rate of μ- its role as a second messenger. However, calpain autolysis and could be part of the while NO rapidly diffuses through tissues, mechanism underlying some of the retarda- NO itself is a relatively short-lived species.
annaabi.ee 
